J.Henderson Gl.Life Sciences F.A2/ IE0009355771 /
| NAV11/27/2023 | Chg.-0.2200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 46.3200USD | -0.47% | reinvestment | Equity | Janus Henderson Inv. ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 11/29/2023 | Public WebStation Live Factsheet | 2023 | English | - |
| 9/11/2023 | Prospectus | 2023 | English | 4,203.60 KB |
| 9/11/2023 | Prospectus | 2023 | German | 5,234.81 KB |
| 9/11/2023 | PRDE20230911-0001995213.pdf | 2023 | German | 118.90 KB |
| 6/30/2023 | Semi-annual report | 2023 | English | 6,997.79 KB |
| 12/31/2022 | Account statment | 2022 | English | 3,262.09 KB |
| 12/31/2022 | Account statment | 2022 | German | 3,512.75 KB |
| 10/1/2022 | Key Investor Information | 2022 | German | 140.18 KB |
| 6/30/2022 | Semi-annual report | 2022 | German | 4,631.53 KB |
| 2/11/2022 | Key Investor Information | 2022 | English | 139.45 KB |